Coral

Coral is a US-based company focused on AI-driven healthcare automation solutions, enhancing patient intake processes through innovative technology that consolidates data from various sources into an efficient, intelligent queue. Coral, founded in 2024 and headquartered in New York, US, specializes in AI-driven healthcare automation. The company recently raised USD 12. 5 mn in Seed funding on April 20, 2026, co-led by Lightspeed Venture Partners and Z47, marking its first deal.

The founder’s history is not publicly detailed. Coral specializes in AI-driven healthcare automation solutions designed to enhance patient intake processes. Their core product consolidates information from diverse channels, including faxes, emails, and CSV files, into a singular intelligent queue, ensuring efficient handling of patient documentation and data. Key functionalities of this solution include automatic tagging and sorting of data, document extraction, eligibility benefits qualification, and synchronization with Electronic Health Records (EHR).

This technology addresses significant challenges such as high staff burnout, processing delays, and revenue leakage. The company serves a diverse client base that includes healthcare providers, pharmaceutical companies, and infusion service centers, primarily operating in the United States and select markets in North America. Coral generates revenue primarily through subscription-based models for its intelligent automation solutions, targeting healthcare organizations seeking to streamline patient intake and operational workflows. The transactions typically involve partnerships with healthcare systems, where clients pay for access to the platform on a recurring basis, enabling them to utilize the full suite of services offered.

Specific pricing plans for these solutions are structured around the volume of data processed and the complexity of the workflows managed, allowing for scalability based on the client's needs. Coral's flagship offerings include automated document processing and patient intake solutions, which deliver measurable efficiencies and improved patient experiences for their users. In April 2026, Coral raised USD 12. 5 mn in Seed funding to expand its AI tools for automating intake, prior authorization, and fax-based workflows across specialty healthcare providers.

The funding will also be utilized to hire additional engineers and healthcare operations staff. The company plans to enhance its product offerings and expand into new markets, focusing on specialty healthcare providers in North America.